TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients
European Journal of Immunology · 2025
DOI: 10.1002/eji.202451480 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Lynda Saber Cherif und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université de Reims Champagne-Ardenne, Reims, France. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Cytokines, Receptors, Cytokine, Respiratory Mucosa. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: University of Reims Champagne-Ardenne (URCA), French National Institute of Health and Medical Research (Inserm), Project Research and Innovation in Inflammatory Respiratory Diseases (RINNOPARI).
Themen: COPD
Abstract (Originalsprache)
Thymic stromal lymphopoietin (TSLP) is an alarmin cytokine activated by allergens, pathogens, and air pollutants. Recent studies suggest TSLP dysregulation in chronic inflammatory diseases. It was highlighted as a key player in the context of asthma‐associated mucosal immunity. This study investigated the production and localization of TSLP and its receptors in airway epithelial cells and the related inflammatory response in chronic obstructive pulmonary disease (COPD) and non‐COPD patients. TSLP transcripts and proteins were detected in epithelial cells but were not abundant at a steady state. The secretion of airway inflammatory mediators was altered in COPD in association with TSLP production. The cellular and molecular characterization of TSLP signaling may identify COPD patients that could benefit from anti‐alarmin therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Reims Champagne-Ardenne, Reims, France.
- Service des maladies respiratoires, CHU de Reims, Reims, France.
- URCATech, Plateforme d'imagerie cellulaire et tissulaire (PICT), Reims, France.
- Département de chirurgie thoracique, CHU de Reims, Hôpital Maison Blanche, Reims, France.
- Service de Pathologie-Oncogénétique, CHU de Reims, Reims, France.
ORCID-Profile: Valérian Dormoy
Förderung
- University of Reims Champagne-Ardenne (URCA)
- French National Institute of Health and Medical Research (Inserm)
- Project Research and Innovation in Inflammatory Respiratory Diseases (RINNOPARI)
- AstraZeneca France
Zitieren
APA
Saber Cherif, L., Devilliers, M. A., Perotin, J. M., Ancel, J., Vivien, A., Bonnomet, A., Delepine, G., Durlach, A., Polette, M., Deslée, G., & Dormoy, V. (2025). TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients. European Journal of Immunology. https://doi.org/10.1002/eji.202451480
Vancouver
Saber Cherif L, Devilliers MA, Perotin JM, Ancel J, Vivien A, Bonnomet A, et al. TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients. European Journal of Immunology. 2025. doi:10.1002/eji.202451480
BibTeX
@article{SaberCherif2025,
author = {Saber Cherif, Lynda and Devilliers, Maëva A and Perotin, Jeanne-Marie and Ancel, Julien and Vivien, Alexandre and Bonnomet, Arnaud and Delepine, Gonzague and Durlach, Anne and Polette, Myriam and Deslée, Gaëtan and Dormoy, Valérian},
title = {TSLP and TSLPr Expression and Localization in the Airways of COPD and Non‐COPD Patients},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202451480}
}
EUVIMED